Global Antiviral Therapy Market Type (Generic Drugs, Branded Drugs) Application (HIV, Hepatitis, Herpes, Virus Influenza, Others) - Global Trends and Forecasts to 2025
Industry Insights
The Global Antiviral Therapy Market is expected to grow at a CAGR of XX % during the forecast period 2018-2025.
The Global Antiviral Therapy Market is segmented on the basis of Type and Application. The Global Antiviral Therapy Market is segmented based on the basis of type Generic Drugs, Branded Drugs. By Application, it is classified as HIV, Hepatitis, Herpes, Virus Influenza, Others. The regional outlook on the Global Antiviral Therapy Market covers regions, such as North America, Europe, Asia-Pacific, and Rest of the World. Global Antiviral Therapy Market for each region is further bifurcated for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Report Scope:
The Global Antiviral Therapy Market report scope covers the in-depth business analysis considering major market dynamics, forecast parameters, and price trends for the industry growth. The report forecasts market sizing at global, regional and country levels, providing comprehensive outlook of industry trends in each market segments and sub-segments from 2017 to 2024. The market segmentations include
Global Antiviral Therapy Market, By Type
Generic Drugs, Branded Drugs
In the same way, the study has divided by applications
Global Antiviral Therapy Market, By Application
HIV, Hepatitis, Herpes, Virus Influenza, Others
Global Antiviral Therapy Market, By Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
The report scope also includes competitive landscape covering the competitive analysis, strategy analysis and company profiles of the major market players. The companies profiled in the report include AbbVie Inc., Abbott, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., Merck & Co., Inc., Gilead Sciences, Inc., GlaxoSmithKline plc, Aurobindo Pharma, AstraZeneca
Report Highlights
- Global Antiviral Therapy Market sizes from 2017 to 2024
- Market growth projections through 2024 and the resultant market forecast for 2024
- Impact of the market dynamics including market drivers, restraints and opportunities in the market size
- Key industry trends, product trends, and application trends
- Major driving/ leading segmentations, regions and countries in the Global Antiviral Therapy Market
- Competitive analysis with comprehensive company profiles of the leading industry players
- In-depth analysis on growth and expansion strategies adopted by market players and their resulting effect on market growth and competition
How this report will add value to your organisation
This report provides the in-depth analysis of the complete value chain from the raw material suppliers to the end users. We have critically analysed following parameters and their impact in the industry:
1. Improvement in top line and bottom line growth
Analysis trend & forecasts by end use markets will help you to understand how the growth in consumption is expected in next 5 years and what will be the key factors that will support the growth. This will help to make a clear plan for the top line growth. Price analytics will also play a crucial role in making a plan for top line growth.
Raw material and other input factors analysis will help to plan effectively for the bottom line.
2. Competitive intelligence
In a competitive marketplace, up-to-date information can make the difference between keeping pace, getting ahead, or being left behind. A smart intelligence operation can serve as an early-warning system for disruptive changes in the competitive landscape, whether that change is a rival's new product or pricing strategy or the entrance of an unexpected player into your market.
We also provide you with information that allows you to anticipate what your competitors are planning next. For example, you might gain information on a new product they are getting ready to launch or new services they will add to the business. Hiring us to handle this information collection saves you time and energy, allowing you to focus on your own business while still gaining the necessary knowledge to keep track of competitors.
3. Identification of prospective customers and their satisfaction level with the current supplier:
We have provided the long list of customers and analysed them critically, based on various parameters such as consumption, market type, sustainable business etc. this will help your organisation to develop relations with the consumers. Also, we have identified the factors in which the others customer will switch to you.
Report Customizations
The customization research services cover the additional custom report features such as additional regional and country level analysis as per the client requirements.
Table of Contents
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2 Porter's Five Force Analysis
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
5. Global Antiviral Therapy Market, By Type
5.1 Introduction
5.2 Generic Drugs, Branded Drugs
5.2.1 Market Overview
5.2.2 Market Size and Forecast
6. Global Antiviral Therapy Market, By Application
6.1 Introduction
6.2 HIV, Hepatitis, Herpes, Virus Influenza, Others
6.2.1 Market Overview
6.2.2 Market Size and Forecast
7. Global Antiviral Therapy Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Antiviral Therapy Market, By Type
7.2.2 North America Antiviral Therapy Market, By Application
7.3 Europe
7.3.1 Europe Antiviral Therapy Market, By Type
7.3.2 Europe Antiviral Therapy Market, By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific Antiviral Therapy Market, By Type
7.4.2 Asia-Pacific Antiviral Therapy Market, By Application
7.5 Rest of the World
7.5.1 Rest of the World Antiviral Therapy Market Drugs, By Type
7.5.2 Rest of the World Antiviral Therapy Market, By Application
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 AbbVie Inc., Abbott, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., Merck & Co., Inc., Gilead Sciences, Inc., GlaxoSmithKline plc, Aurobindo Pharma, AstraZeneca
TABLE 1 Antiviral Therapy Market KEY MARKET SEGMENTS IN THIS STUDY 16
TABLE 2 KEY MANUFACTURERS Antiviral Therapy Market COVERED IN THIS STUDY 16
TABLE 3 GLOBAL Antiviral Therapy Market MARKET SIZE GROWTH RATE BY TYPE (2018-2025) (MILLION UNITS) & (MILLION US$) 17
TABLE 4 GLOBAL Antiviral Therapy Market MARKET SIZE GROWTH RATE BY APPLICATION (2018-2025) (MILLION UNITS) 20
TABLE 5 GLOBAL Antiviral Therapy Market CONSUMPTION MARKET SHARE BY APPLICATION IN 2017 20
TABLE 6 GLOBAL Antiviral Therapy Market MARKET SIZE GROWTH RATE BY REGIONS 2018-2025(MILLION UNITS) & (MILLION USD) 24
TABLE 7 GLOBAL MANUFACTURERS MARKET CONCENTRATION RATIO (CR5 AND HHI) 24
TABLE 8 Antiviral Therapy Market MANUFACTURING BASE DISTRIBUTION AND HEADQUARTERS) 25
TABLE 9 MANUFACTURERS Antiviral Therapy Market PRODUCT OFFERED 25
TABLE 10 DATE OF MANUFACTURERS ENTER INTO Antiviral Therapy Market MARKET 26
TABLE 11 KEY TRENDS FOR Antiviral Therapy Market MARKETS & PRODUCTS 26
TABLE 12 GLOBAL Antiviral Therapy Market PRODUCTION BY MANUFACTURERS (2013-2018) (MILLION UNITS) 27
TABLE 13 GLOBAL Antiviral Therapy Market PRODUCTION SHARE BY MANUFACTURERS (2013-2018) 27
TABLE 14 Antiviral Therapy Market REVENUE BY MANUFACTURERS (2013-2018) (MILLION USD) 28
TABLE 15 Antiviral Therapy Market REVENUE SHARE BY MANUFACTURERS (2013-2018) 29
TABLE 16 MERGERS & ACQUISITIONS, EXPANSION PLANS 29
TABLE 17 GLOBAL Antiviral Therapy Market PRODUCTION BY REGIONS 2013-2018 (MILLION UNITS) 30
TABLE 18 GLOBAL Antiviral Therapy Market PRODUCTION MARKET SHARE BY REGIONS 2013-2018 30
TABLE 19 GLOBAL Antiviral Therapy Market REVENUE BY REGIONS 2013-2018 (MILLION USD) 32
TABLE 20 GLOBAL Antiviral Therapy Market REVENUE MARKET SHARE BY REGIONS 2013-2018 32
TABLE 21 UNITED STATES Antiviral Therapy Market IMPORT & EXPORT (MILLION UNITS) 35
TABLE 22 EUROPE Antiviral Therapy Market IMPORT & EXPORT 37
TABLE 23 CHINA Antiviral Therapy Market IMPORT & EXPORT 39
TABLE 24 JAPAN Antiviral Therapy Market IMPORT & EXPORT 41
TABLE 25 SOUTH KOREA Antiviral Therapy Market IMPORT & EXPORT 43
TABLE 26 GLOBAL Antiviral Therapy Market CONSUMPTION BY REGIONS 2013-2018 (MILLION UNITS) 44
TABLE 27 GLOBAL Antiviral Therapy Market CONSUMPTION MARKET SHARE BY REGION 2013-2018 44
TABLE 28 UNITED STATES Antiviral Therapy Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 46
TABLE 29 UNITED STATES Antiviral Therapy Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 47
TABLE 30 EUROPE Antiviral Therapy Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 49
TABLE 31 EUROPE Antiviral Therapy Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 49
TABLE 32 CHINA Antiviral Therapy Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 51
TABLE 33 CHINA Antiviral Therapy Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 51
TABLE 34 JAPAN Antiviral Therapy Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 53
TABLE 35 JAPAN Antiviral Therapy Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 53
TABLE 36 SOUTH KOREA Antiviral Therapy Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 55
TABLE 39 SOUTH KOREA Antiviral Therapy Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 55
TABLE 40 GLOBAL Antiviral Therapy Market PRODUCTION BY TYPE (2013-2018) (MILLION UNITS) 57
TABLE 41 GLOBAL Antiviral Therapy Market PRODUCTION SHARE BY TYPE (2013-2018) 57
TABLE 42 GLOBAL Antiviral Therapy Market REVENUE BY TYPE (2013-2018) (MILLION USD) 59
TABLE 43 GLOBAL Antiviral Therapy Market REVENUE SHARE BY TYPE (2013-2018) 59
TABLE 44 Antiviral Therapy Market PRICE BY SMART LENSES013-2018 (USD/UNIT) 61
TABLE 45 GLOBAL Antiviral Therapy Market CONSUMPTION BY APPLICATION (2013-2025) (MILLION UNITS) 62
TABLE 46 GLOBAL Antiviral Therapy Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 62
TABLE 47 GLOBAL Antiviral Therapy Market CONSUMPTION SHARE BY APPLICATION (2013-2018) 63
TABLE 48 COMPANY 1 COMPANY DETAILS 64
TABLE 49 COMPANY 1 DESCRIPTION AND BUSINESS OVERVIEW 64
TABLE 50 COMPANY 1 Antiviral Therapy Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 65
TABLE 52 COMPANY 1 Antiviral Therapy Market PRODUCT 65
TABLE 53 COMPANY 2 RECENT DEVELOPMENT 65
TABLE 54 COMPANY 2 COMPANY DETAILS 66
TABLE 55 COMPANY 3 DESCRIPTION AND BUSINESS OVERVIEW 66
TABLE 56 COMPANY 3 Antiviral Therapy Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 67
TABLE 57 COMPANY 3 Antiviral Therapy Market PRODUCT 67
TABLE 58 COMPANY 3 RECENT DEVELOPMENT 67
TABLE 59 COMPANY 3 COMPANY DETAILS 68
TABLE 60 COMPANY 3 DESCRIPTION AND BUSINESS OVERVIEW 68
TABLE 61 COMPANY 3 Antiviral Therapy Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 69
TABLE 62 COMPANY 3 Antiviral Therapy Market PRODUCT 69
TABLE 63 COMPANY 3 RECENT DEVELOPMENT 70
TABLE 64 COMPANY 4 COMPANY DETAILS 71
TABLE 65 COMPANY 4 DESCRIPTION AND BUSINESS OVERVIEW 71
TABLE 66 Antiviral Therapy Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 72
TABLE 67 COMPANY 4 Antiviral Therapy Market PRODUCT 72
TABLE 68 COMPANY 4 RECENT DEVELOPMENT 73
TABLE 69 COMPANY 5 OPTICAL COMPANY DETAILS 73
TABLE 70 COMPANY 5 DESCRIPTION AND BUSINESS OVERVIEW 74
TABLE 71 COMPANY5 Antiviral Therapy Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 74
TABLE 72 COMPANY 5 OPTICAL Antiviral Therapy Market PRODUCT 74
TABLE 73 COMPANY 5 OPTICAL RECENT DEVELOPMENT 74
TABLE 74 COMPANY 6 COMPANY DETAILS 75
TABLE 75 COMPANY 6 DESCRIPTION AND BUSINESS OVERVIEW 75
TABLE 76 COMPANY 6 Antiviral Therapy Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 76
TABLE 77 COMPANY 6 Antiviral Therapy Market PRODUCT 76
TABLE 78 COMPANY 7 GLOBAL COMPANY DETAILS 77
TABLE 79 COMPANY 7 DESCRIPTION AND BUSINESS OVERVIEW 77
TABLE 80 COMPANY 7 GLOBAL Antiviral Therapy Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 77
TABLE 81 COMPANY 7 GLOBAL Antiviral Therapy Market PRODUCT 78
TABLE 82 COMPANY 8 VISION COMPANY DETAILS 79
TABLE 83 COMPANY 8 DESCRIPTION AND BUSINESS OVERVIEW 79
TABLE 84 COMPANY 8 Antiviral Therapy Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 80
TABLE 85 COMPANY 8 Antiviral Therapy Market PRODUCT 80
TABLE 86 COMPANY 9 COMPANY DETAILS 81
TABLE 87 COMPANY 9 DESCRIPTION AND BUSINESS OVERVIEW 81
TABLE 88 COMPANY 9 Antiviral Therapy Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 81
TABLE 89 COMPANY 9 Antiviral Therapy Market PRODUCT 82
TABLE 90 COMPANY 10 COMPANY DETAILS 83
TABLE 91 COMPANY 10 DESCRIPTION AND BUSINESS OVERVIEW 83
TABLE 92 COMPANY 10 Antiviral Therapy Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 83
TABLE 93 COMPANY 10 Antiviral Therapy Market PRODUCT 84
TABLE 94 GLOBAL Antiviral Therapy Market REVENUE FORECAST BY REGIONS 2018-2025 (MILLION USD) 86
TABLE 95 GLOBAL Antiviral Therapy Market PRODUCTION FORECAST BY REGIONS 2018-2025 (MILLION UNITS) 87
TABLE 96 GLOBAL Antiviral Therapy Market PRODUCTION FORECAST BY TYPE (2018-2025) (MILLION UNITS) 94
TABLE 97 Antiviral Therapy Market REVENUE FORECAST BY TYPE (2018-2025) (MILLION USD) 95
TABLE 98 GLOBAL Antiviral Therapy Market CONSUMPTION FORECAST BY APPLICATION (2018-2025) (MILLION UNITS) 96
TABLE 99 GLOBAL Antiviral Therapy Market CONSUMPTION FORECAST BY REGIONS 2018-2025 (MILLION UNITS) 97
TABLE 100 Antiviral Therapy Market DISTRIBUTORS LIST 103
TABLE 101 KEY OPPORTUNITIES AND DRIVERS 104
TABLE 102 KEY CHALLENGES 104
TABLE 103 MARKET RISKS 104
TABLE 104 RESEARCH PROGRAMS/DESIGN FOR THIS REPORT 108
TABLE 105 KEY DATA INFORMATION FROM SECONDARY SOURCES 112
TABLE 106 KEY DATA INFORMATION FROM PRIMARY SOURCES 113
